Legal Representation
Attorney
Nyall Engfield
USPTO Deadlines
Next Deadline
1169 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230228)
Due Date
February 28, 2029
Grace Period Ends
August 28, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 28, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 28, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 13, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 13, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 23, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 10, 2022 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
| Nov 4, 2022 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Oct 29, 2022 | AAUA | E | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | Loading... |
| Oct 28, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 28, 2022 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
| Oct 10, 2022 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
| Oct 10, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 8, 2022 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
| Oct 3, 2022 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Sep 25, 2022 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 25, 2022 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 25, 2022 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Sep 25, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 9, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 8, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Homeopathic pharmaceuticals for use in the treatment of flu and flu-like symptoms, namely, body aches, headaches, fever, sore throat, tiredness and chills
First Use Anywhere:
Sep 23, 2022
First Use in Commerce:
Sep 23, 2022
Classification
International Classes
005